Peking University: Breast Neoplasms trials

The registry lists 17 Breast Neoplasms studies with Peking University as lead sponsor. 5 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 2Phase 3 1Phase 4 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast CancerEnrolling by invitationNCT06650748Phase 2
• Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral NeuropathyRecruitingNCT05341141Not applicable
• Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACTRecruitingNCT05314114Not applicable
• Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast CancerRecruitingNCT04481932Phase 2
• Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast CancerRecruitingNCT02535221Phase 3
• Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast CancerStatus unknownNCT05767931
• Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or ChemotherapyCompletedNCT05673850
• Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast CancerStatus unknownNCT05417048
• CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NACStatus unknownNCT04457700
• Integrin α6-targeted SPECT Imaging of Breast CancerCompletedNCT04289532Early Phase 1
• Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast CancerCompletedNCT04009941Phase 4
• To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph NodesStatus unknownNCT03715686Not applicable
• Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant ChemotherapyStatus unknownNCT03381092
• Computed Tomography (CT) Reconstruction for Axillary Lymph Node StructureCompletedNCT03247478
• The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive ChemotherapyCompletedNCT02944604Phase 4
• The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After ChemotherapyStatus unknownNCT02905916Phase 4
• Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.CompletedNCT02773784